$134 Million is the total value of HealthInvest Partners AB's 15 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 50.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CAH | Buy | CARDINAL HEALTH INC | $17,933,000 | +43.7% | 230,800 | +44.2% | 13.34% | +133.2% |
ABC | Buy | AMERISOURCEBERGEN CORP | $17,125,000 | +34.9% | 212,000 | +32.5% | 12.74% | +119.0% |
ANTM | Buy | ANTHEM INC | $17,030,000 | +38.1% | 135,900 | +44.7% | 12.67% | +124.1% |
INCR | Sell | INC RESH HLDGS INCcl a | $9,936,000 | -9.0% | 222,875 | -22.1% | 7.39% | +47.7% |
CRL | Sell | CHARLES RIV LABS INTL INC | $9,885,000 | -19.9% | 118,612 | -20.7% | 7.36% | +30.1% |
GNCIQ | Sell | GNC HLDGS INC | $9,862,000 | -40.5% | 482,955 | -29.2% | 7.34% | -3.4% |
MRK | Sell | MERCK & CO INC | $9,805,000 | -24.1% | 157,100 | -29.9% | 7.30% | +23.2% |
ANIK | Sell | ANIKA THERAPEUTICS INC | $9,737,000 | -56.0% | 203,493 | -50.7% | 7.25% | -28.6% |
GTS | Sell | TRIPLE-S MGMT CORPcl b | $9,428,000 | -27.6% | 429,904 | -19.3% | 7.02% | +17.5% |
TARO | Sell | TARO PHARMACEUTICAL INDS LTD | $9,416,000 | -25.0% | 85,205 | -1.2% | 7.01% | +21.8% |
SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $9,386,000 | -29.9% | 379,533 | -42.3% | 6.98% | +13.7% |
PGNX | New | PROGENICS PHARMACEUTICALS IN | $1,772,000 | – | 280,000 | +100.0% | 1.32% | – |
ICCC | IMMUCELL CORP | $1,301,000 | +12.1% | 168,323 | 0.0% | 0.97% | +82.0% | |
BIL | New | SPDR SERIES TRUSTbrclys 1-3mt etf | $915,000 | – | 20,000 | +100.0% | 0.68% | – |
SHY | New | ISHARES TR1-3 yr tr bd etf | $850,000 | – | 10,000 | +100.0% | 0.63% | – |
OSUR | Exit | ORASURE TECHNOLOGIES INC | $0 | – | -475,771 | -100.0% | -1.29% | – |
INSYQ | Exit | INSYS THERAPEUTICS INC NEW | $0 | – | -788,175 | -100.0% | -4.68% | – |
CXRXF | Exit | CONCORDIA INTL CORP | $0 | – | -543,000 | -100.0% | -5.36% | – |
LPNT | Exit | LIFEPOINT HEALTH INC | $0 | – | -185,851 | -100.0% | -5.57% | – |
FEIC | Exit | FEI CO | $0 | – | -118,609 | -100.0% | -5.81% | – |
AMAG | Exit | AMAG PHARMACEUTICALS INC | $0 | – | -671,585 | -100.0% | -7.37% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-10-24
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
MCKESSON CORP | 14 | Q3 2022 | 14.6% |
ANTHEM INC | 12 | Q4 2017 | 14.3% |
TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-25 |
13F-HR | 2024-01-30 |
13F-HR | 2023-02-14 |
13F-HR | 2022-10-21 |
13F-HR | 2022-07-08 |
13F-HR | 2022-05-05 |
13F-HR | 2022-01-18 |
13F-HR | 2021-11-08 |
13F-HR | 2021-08-10 |
13F-HR | 2021-04-30 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.